Control Bionics Wins Australian Registration for NeuroStrip, Completing Four-Market Rollout
CBL: $0.048 -5.88% · MC: $29M
Control Bionics’ NeuroStrip wearable device has been included on Australia’s medical device register as a Class I device, allowing the company to supply it locally. The registration adds Australia to the US, Great Britain and European markets where NeuroStrip is already registered; the company says its focus is now on winning customers and partners.

Comments